Get started
Author

Björn A. Menge

Loss of Inverse Relationship Between Pulsatile Insulin and Glucagon Secretion in Patients With Type 2 Diabetes
2011 · Björn A. Menge, Lena Grüber, et al. · Diabetes · 134
PDF
Effects of Lixisenatide Versus Liraglutide (Short- and Long-Acting GLP-1 Receptor Agonists) on Esophageal and Gastric Function in Patients With Type 2 Diabetes
2020 · Daniel R. Quast, Nina Schenker, et al. · Diabetes Care · 65
Impaired Crosstalk between Pulsatile Insulin and Glucagon Secretion in Prediabetic Individuals
2012 · Stefan Rohrer, Björn A. Menge, et al. · The Journal of Clinical Endocrinology & Metabolism · 44
Macronutrient intake, appetite, food preferences and exocrine pancreas function after treatment with short‐ and long‐acting glucagon‐like peptide‐1 receptor agonists in type 2 diabetes
2021 · Daniel R. Quast, Michael A. Nauck, et al. · Diabetes Obesity and Metabolism · 40
PDF
Upper gastrointestinal motility and symptoms in individuals with diabetes, prediabetes and normal glucose tolerance
2015 · Georgios C. Boronikolos, Björn A. Menge, et al. · Diabetologia · 40
PDF
Chronic Reduction of Fasting Glycemia With Insulin Glargine Improves First- and Second-Phase Insulin Secretion in Patients With Type 2 Diabetes
2011 · Christian Pennartz, Nina Schenker, et al. · Diabetes Care · 38
Defects in α-Cell Function in Patients With Diabetes Due to Chronic Pancreatitis Compared With Patients With Type 2 Diabetes and Healthy Individuals
2017 · Lena Mumme, Thomas G.K. Breuer, et al. · Diabetes Care · 29
Effects of sequential treatment with lixisenatide, insulin glargine, or their combination on meal‐related glycaemic excursions, insulin and glucagon secretion, and gastric emptying in patients with type 2 diabetes
2019 · Juris J. Meier, Björn A. Menge, et al. · Diabetes Obesity and Metabolism · 23
PDF
Impact of insulin glargine and lixisenatide on β‐cell function in patients with type 2 diabetes mellitus: A randomized open‐label study
2017 · Juris J. Meier, Nina Schenker, et al. · Diabetes Obesity and Metabolism · 10
Author response for "Macronutrient intake, appetite, food preferences and exocrine pancreas function after treatment with short‐ and long‐acting GLP ‐1 receptor agonists in type 2 diabetes"
2021 · Daniel R. Quast, Michael A. Nauck, et al. · Publons reviews and discussion
Author response for "Effects of sequential treatment with lixisenatide, insulin glargine , or their combination on meal‐related glycaemic excursions, insulin and glucagon secretion, and gastric emptying in patients with type 2 diabetes"
2019 · Juris J. Meier, Björn A. Menge, et al. · Publons reviews and discussion
GLP-1: ein neues Therapieprinzip für die Behandlung des Diabetes mellitus Typ 2
2010 · Björn A. Menge, Juris J. Meier, et al. · Medizinische Klinik - Intensivmedizin und Notfallmedizin
Works count: 13
Citation count: 423
H-index: 9
I10-index: 9
Year
Topic
Type